Cephalon logo

Home page    |    Contact us    |    Cephalon websites    |    Site map  

 

 


Health improvement is a key indicator of the state of advancement of a society. Through our research & development efforts, Cephalon contributes to the never ending challenges that sickness and disease pose to our healthcare system. We thrive to provide affordable medicines that make a difference.
 

Finding new therapeutic solutions for unmet medical needs inspires us as a company. In the mid-1990’s, Cephalon began its operations in Europe by treating disabling excessive daytime sleepiness associated with narcolepsy, which until that time had been inadequately addressed.   Today, Cephalon is bringing its innovative perspective to areas such as breakthrough cancer pain, metastatic breast cancer and severe types of leukaemias.
Innovation and services for patients and healtcare professionals are a day-to-day commitment for all employees at Cephalon. 
  

 Through the recent acquisition of the Swiss generic Company Mepha, Cephalon provides 150 products and is now able to respond to various needs in the Specialty Pharma and the Generics areas. Providing access to innovation at a cost affordable for the payers is also an important objective to be achieved (25/05/10).

 

 

 

 Alain Aragues
Executive Vice President
&  President Cephalon Europe
Chairman of the Management Board 
of Mepha GmbH 
 

 

 

WE ARE DRIVEN

Our mission is to discover and develop innovative drugs to improve patients’ lives. Cephalon provides a range of specialty as well as branded generic and generic products to healthcare professionals and patients in over 100 countries, covering Western and Central Europe, the Middle East and Africa.

 

   NEWS

- Cephalon participated in the 6th Research Congress of the European Association for Palliative Care (EAPC) in Glasgow, UK, June 9 to 12, 2010. (29/06/10) >>

- Cephalon completes Acquisition of Swiss Pharmaceutical Company Mepha. Acquisition diversifies global pharmaceutical business and expends presence in Western and Central Europe, Africa and Middle East Territories (09/04/10)
>>

  
   GOING GREEN

Cephalon Germany offices have moved to an “environment friendly building”, located in the centre of Munich...>>

  

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.